Literature DB >> 1897610

Substance abuse disorders: a psychiatric priority. Group for the Advancement of Psychiatry Committee on Alcoholism and the Addictions.

.   

Abstract

The renewed public, governmental, and professional interest in addictive disorders should serve to encourage the interest of psychiatrists in this important and rapidly changing field. It is the view of the Group for the Advancement of Psychiatry (GAP) Committee on Alcoholism and the Addictions that all psychiatrists should possess expertise in the recognition, assessment, and treatment of substance use disorders. This position paper by the GAP committee reviews the role of the psychiatrist in the evaluation and treatment of patients with substance use disorders. It also notes some of the obstacles to full involvement in this field by medical practitioners in general and psychiatrists in particular. The psychiatrist has a critical role to play in the diagnosis and treatment of patients with substance use disorders. As biopsychosocial phenomena, substance abuse problems constitute a special and direct challenge to the psychiatrist, whose training, perspective, and competence should span all three domains. Psychiatrists must be willing to accept this challenge and fully participate in the development and application of treatment strategies adequate to cope with the enormous human suffering resulting from the abuse of alcohol and other psychoactive drugs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1897610     DOI: 10.1176/ajp.148.10.1291

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

1.  Use of potentially abusive psychotropic substances in psychiatric inpatients.

Authors:  J Modestin; C Nussbaumer; K Angst; P Scheidegger; D Hell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  Training in Substance-Related and Addictive Disorders, Part 2: Updated Curriculum Guidelines.

Authors:  David Crockford; Gilles Fleury; Robert Milin; Leslie Buckley; Dara Charney; Tony P George; Nady el-Guebaly
Journal:  Can J Psychiatry       Date:  2015-12       Impact factor: 4.356

3.  Addiction medicine and addiction psychiatry in America: Commonalities in the medical treatment of addiction.

Authors:  Christopher R Freed
Journal:  Contemp Drug Probl       Date:  2010

4.  Fundamental Causes of Housing Loss among Persons Diagnosed with Serious and Persistent Mental Illness: A Theoretically Guided Test.

Authors:  Russell K Schutt; Stephen M Goldfinger
Journal:  Asian J Psychiatr       Date:  2009-12-01

Review 5.  Psychosocial and clinical predictors of response to pharmacotherapy for depression.

Authors:  R Michael Bagby; Andrew G Ryder; Carolina Cristi
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

6.  Primary care-based ambulatory opioid detoxification: the results of a clinical trial.

Authors:  P G O'Connor; M E Waugh; K M Carroll; B J Rounsaville; I A Diagkogiannis; R S Schottenfeld
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

7.  Addiction medicine and addiction psychiatry in America: The impact of physicians in recovery on the medical treatment of addiction.

Authors:  Christopher R Freed
Journal:  Contemp Drug Probl       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.